BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Paul Harkin; Judith Carser; Jennifer Quinn-O'Brien; C.O. Michie; E O'Brien; W.G. McCluggage; Perry Maxwell; Elisabeth Lamers-Schmidt; TF Loie; AR Williams; Richard Kennedy

doi:10.1016/j.ygyno.2011.08.017

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Paul Harkin
, Judith Carser
, Jennifer Quinn-O'Brien
, C.O. Michie
, E O'Brien
, W.G. McCluggage
, Perry Maxwell
, Elisabeth Lamers-Schmidt
, TF Loie
, AR Williams
, Richard Kennedy

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	492-498
Number of pages	7
Journal	Gynecologic Oncology
Volume	123(3)
Issue number	3
DOIs	https://doi.org/10.1016/j.ygyno.2011.08.017
Publication status	Published - Dec 2011

ASJC Scopus subject areas

Obstetrics and Gynaecology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ygyno.2011.08.017

Cite this

Harkin, P., Carser, J., Quinn-O'Brien, J., Michie, C. O., O'Brien, E., McCluggage, W. G., Maxwell, P., Lamers-Schmidt, E., Loie, TF., Williams, AR., & Kennedy, R. (2011). BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer. Gynecologic Oncology, 123(3)(3), 492-498. https://doi.org/10.1016/j.ygyno.2011.08.017

@article{abca0264dd9545e2bfbb82c1c3331aee,

title = "BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.",

author = "Paul Harkin and Judith Carser and Jennifer Quinn-O'Brien and C.O. Michie and E O'Brien and W.G. McCluggage and Perry Maxwell and Elisabeth Lamers-Schmidt and TF Loie and AR Williams and Richard Kennedy",

year = "2011",

month = dec,

doi = "10.1016/j.ygyno.2011.08.017",

language = "English",

volume = "123(3)",

pages = "492--498",

journal = "Gynecologic Oncology",

issn = "1095-6859",

publisher = "Academic Press Inc.",

number = "3",

}

Harkin, P, Carser, J, Quinn-O'Brien, J, Michie, CO, O'Brien, E, McCluggage, WG, Maxwell, P, Lamers-Schmidt, E, Loie, TF, Williams, AR & Kennedy, R 2011, 'BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.', Gynecologic Oncology, vol. 123(3), no. 3, pp. 492-498. https://doi.org/10.1016/j.ygyno.2011.08.017

TY - JOUR

T1 - BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

AU - Harkin, Paul

AU - Carser, Judith

AU - Quinn-O'Brien, Jennifer

AU - Michie, C.O.

AU - O'Brien, E

AU - McCluggage, W.G.

AU - Maxwell, Perry

AU - Lamers-Schmidt, Elisabeth

AU - Loie, TF

AU - Williams, AR

AU - Kennedy, Richard

PY - 2011/12

Y1 - 2011/12

U2 - 10.1016/j.ygyno.2011.08.017

DO - 10.1016/j.ygyno.2011.08.017

M3 - Article

C2 - 21920589

SN - 1095-6859

VL - 123(3)

SP - 492

EP - 498

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 3

ER -